Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine

Veterinary Therapeutics

Volumn 7, Issue 1, 2006, Pages 27-34

  Brock, K V ^a   McCarty, K ^b   Chase, C C L ^c   Harland, R ^b  

^a AUBURN UNIVERSITY   (United States)

^b Novartis Animal Health   (United States)

^c SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE DIARRHEA VIRUS; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 1, BOVINE VIRAL; DIARRHEA VIRUS 2, BOVINE VIRAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; PREGNANCY; TREATMENT OUTCOME; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

ANIMALIA; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 33645955274     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Baker JC: The clinical manifestations of bovine viral diarrhea infections. Vet Clin North Am Food Anim Pract 11:425-446, 1995.
2. Ridpath JF, Bolin SR, Dubovi EJ: Segregation of bovine viral diarrhea virus into genotypes. Virology 205:66-74, 1994.
3. Fulton RW, Ridpath JF, Saliki JT et at: Bovine viral diarrhea virus (BVDV) 1b: Predominant BVDV subtype in calves with respiratory disease. Can J Vet Res 66:181-190, 2002.
4. North Central Regional Committee on Bovine Respiratory Disease (NC-107). Annual Reports, Animal Disease Research and Diagnostic Laboratory, South Dakota State University, Brookings, SD, 1991-2004. (Available on request from Animal Disease Research and Diagnostic Laboratory.)
5. McClurkin AW, Littledike ET, Cutlip RC, et al: Production of cattle immunotolerant to bovine viral diarrhea virus (BVDV). Can J Comp Med 48:156-161, 1994.
6. Loneragan GH, Thomson DU, Montgomery DL, et al: Prevalence, outcome, and health consequences associated with persistent infection with bovine viral diarrhea virus in feedlot cattle. JAVMA 226:595-601, 2005.
7. Brownlie J, Clarke MC, Howard CJ: Experimental production of fatal mucosal disease in cattle. Vet Rec 114:535-536, 1984.
8. Fairbanks KK, Rinehart CL, Ohnesorge WC, et al: Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine. JAVMA 225:1898-1904, 2004.
9. Martinez MF, Kasatelic JP, Adams GP, Mapletoft RJ: The use of a progesterone-releasing device (CIDR-B) or melengestrol acetate with GnRH, LH, or estradiol benzoate for Fixed-time AI in beef heifers. J Anim Sci 80:1746-1751, 2002.
10. Cortese VS, Grooms DL, Ellis J, et al: Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type-1 by use of a modified-live virus vaccine. Am J Vet Res 59:1409-1413, 1998.
11. Brock KV, Cortese VS: Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Ther 2:354-360, 2001.
12. Deng R, Brock KV: Molecular cloning and nucleotide sequence of a pestivirus genome, noncytopathic bovine viral diarrea virus strain SD-1. Virology 191: 867-879, 1992.
13. Dean HJ, Hunsaker BD, Bailey OD, et al: Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. Am J Vet Res 64:530-537, 2003.
14. Kovacs F, Magyar T, Rinehart CL, et al: The live attenuated bovine viral diarrhea virus components of a multivalent vaccine confer protection against fetal infection. Vet Microbiol 96(2):117-131, 2003.
15. Van Campen H, Vorpahl P, Huzurbazar S, et al: A case report: Evidence for type 2 bovine viral diarrhea virus (BVDV)-associated disease in beef herds vaccinated with a modified-live type 1 BVDV vaccine. J Vet Diagn Invest 12:263-265, 2000.
16. Becher P, Orlich M, Thiel H-J: RNA recombination between persisting pestivirus and a vaccine strain: Generation of cytopathogenic virus and induction of lethal disease. J Virol 75:6256-6264, 2001.
17. Gallei A, Pankraz A, Thiel H-J, et al: RNA recombination in vivo in the absence of viral replication. J Virol 78:6271-6281, 2004.
18. Lambot M, Douart A, Joris E, et at: Characterization of the immune response of cattle against non-cytopathic and cytopathic biotypes of bovine viral diarrhoea virus. J Gen Virol 78:1041-1047, 1997.
19. Harding MJ, Cao X, Shams H, et al: Role of bovine viral diarrhea virus biotype in the establishment of fetal infections. Am J Vet Res 63:1455-1463, 2002.
20. Spagnuolo-Weaver M, Allan GM, Kennedy S, et al: Distribution of cytopathic and noncytopathic bovine viral diarrhea virus antigens in tissues of calves following acute experimental infection. J Vet Diagn Invest 9:287-297, 1997.
21. Liebler-Tenorio EM, Ridpath JF, Neill JD: Distribution of viral antigen and development of lesions after experimental infection of calves with a BVDV 2 strain of low virulence. J Vet Diagn Invest 15:221-232, 2003.
22. Liebler-Tenorio EM, Ridpath JF, Neill JD: Distribution of viral antigen and tissue lesions in persistent and acute infection with the homologous strain of noncytopathic bovine viral diarrhea virus. J Vet Diagn Invest 16:388-396, 2004.
23. Baule C, Kulcsar G, Belak K, et al: Pathogenesis of primary respiratory disease induced by isolates from a new genetic cluster of bovine viral diarrhea virus type I. J Clin Microbiol 39:146-153, 2001.
24. Brackenbury LS, Carr BV, Charleston B: Aspects of the innate and adaptive immune responses to acute infections with BVDV. Vet Micro 96:337-344, 2003.
25. Lambot M, Joris E, Douart A, et al: Evidence for biotype-specific effects of bovine viral diarrhoea virus on biological responses in acutely infected calves. J Gen Virol 79:27-30, 1998.